CD4 and cancer: The less abundance of Temra cells in tumors based on scRNA‐seq analysis is consistent with previous observations by traditional flow cytometry analysis (identified as CD45RA+CCR7− CD4+ or CD8+ T cells) in multiple cancer types.131, 132, 133, 134